Skip to main content
Admissions guidance, study banks, and career tools — get started on Shalyam
Research News

Why Rheumatoid Arthritis Pain Persists Even with Treatment

Mayur Tembhare
  1. Rheumatoid arthritis is a chronic autoimmune disease that affects tens of thousands of people in Hungary alone.

  2. -28 percent of patients with rheumatoid arthritis fall into the 'difficult-to-treat' group because they don't achieve lasting remission despite therapy.

  3. The researchers developed a new model to help doctors identify underlying causes and tailor treatment for difficult-to-treat rheumatoid arthritis.

  4. The team's model has gained substantial international attention, with publications already cited over a thousand times by other researchers.

Why Rheumatoid Arthritis Pain Persists Even with Treatment

Topic: Health

Researchers at Semmelweis University found that rheumatoid arthritis pain can persist even when inflammation is under control. They developed a model to help doctors identify underlying causes and tailor treatment.

Rheumatoid arthritis is a chronic autoimmune disease where the immune system attacks joints, causing pain, swelling, and stiffness. It affects tens of thousands of people in Hungary alone. Most patients respond well to treatment, but 6-28 percent fall into the 'difficult-to-treat' group because they don't achieve lasting remission despite therapy.

Researchers at Semmelweis University examined how depression, smoking, obesity, sleep problems, and other health conditions are connected with difficult-to-treat rheumatoid arthritis. They found that these additional health problems may contribute to keeping symptoms active, creating a 'vicious cycle' of pain, mood, and sleep. For example, pain and depression can reduce physical activity, leading to weight gain and worsening both sleep and mood.

The researchers developed a new model that could improve care for patients whose rheumatoid arthritis remains difficult to manage. They suggest using the widely used 'treat-to-target' approach as an 'early warning system'. If measurable signs of inflammation improve but symptoms remain, it may indicate that pain or fatigue is not being caused solely by ongoing inflammation. In such cases, doctors should look for what is maintaining the symptoms and focus treatment on that.

The team's model has gained substantial international attention, with publications already cited over a thousand times by other researchers. The definition of 'difficult-to-treat' disease is now used worldwide not only for rheumatoid arthritis but also in discussions of other diseases.

Why It Matters

This research can help doctors provide better care to patients with rheumatoid arthritis, which affects millions of people worldwide. It also highlights the importance of considering underlying health conditions when treating chronic pain and autoimmune diseases.

Key Facts

  • Rheumatoid arthritis is a chronic autoimmune disease that affects tens of thousands of people in Hungary alone.
  • 6-28 percent of patients with rheumatoid arthritis fall into the 'difficult-to-treat' group because they don't achieve lasting remission despite therapy.
  • The researchers developed a new model to help doctors identify underlying causes and tailor treatment for difficult-to-treat rheumatoid arthritis.
  • The team's model has gained substantial international attention, with publications already cited over a thousand times by other researchers.
  • The definition of 'difficult-to-treat' disease is now used worldwide not only for rheumatoid arthritis but also in discussions of other diseases.

Key Terms

Autoimmune disease
A condition where the immune system mistakenly attacks healthy tissues, leading to chronic pain and inflammation.
Treat-to-target approach
A widely used method where doctors regularly track measurable indicators of disease activity and adjust treatment accordingly.

Implications

This research can help doctors provide better care to patients with rheumatoid arthritis, which affects millions of people worldwide. It also highlights the importance of considering underlying health conditions when treating chronic pain and autoimmune diseases.

Source: https://www.sciencedaily.com/releases/2026/09/260925093208.htm

Journal reference:

  1. Lilla Gunkl-Tóth, Iain B. McInnes, György Nagy. Bridging the gap: combining treat-to-target and difficult-to-treat strategies in the management of rheumatoid arthritis. Nature Reviews Rheumatology, 2026; 22 (5): 319 DOI: 10.1038/s41584-026-01354-w
  2. Wenhui Xie, Tong Chen, Yuan Chen, Zhuoli Zhang, Shiyu Xiao. Associated lifestyle factors and comorbidities of difficult-to-treat rheumatoid arthritis: a systematic review and meta-analysis. The Lancet Rheumatology, 2026; 8 (6): e425 DOI: 10.1016/S2665-9913(26)00041-X
  3. Lilla Gunkl-Tóth, György Nagy. Lifestyle factors in difficult-to-treat rheumatoid arthritis. The Lancet Rheumatology, 2026; 8 (6): e408 DOI: 10.1016/S2665-9913(26)00108-6

Leave a comment

← All research

Get Exclusive Insights with Every Issue

Join Shalyam Newsletter

Stay ahead in education, research, and innovation—straight to your inbox.